Clinical trial
Study Evaluating the Effects of IMA-638 on Allergen-Induced Airway Responses in…
NCT00410280 · Pfizer, Industry · Completed
Key facts
| NCT number | NCT00410280 |
|---|---|
| Title | Study Evaluating the Effects of IMA-638 on Allergen-Induced Airway Responses in Subjects With Mild Atopic Asthma |
| Official title | Allergen Challenge |
| Lead sponsor | Pfizer, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Asthma |
| Intervention type | Biological |
| Interventions | IMA-638 is a biologic |
| Enrollment | 30 |
| Start date | Mar 1, 2007 |
| Primary completion | May 1, 2008 |
| Completion | May 1, 2008 |
| First posted | Dec 12, 2006 |
| Last update posted | Nov 18, 2014 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: